Role of NT‐proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants
Authors:
- 23 December 2019
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (2) , 376-382
Abstract
Objective: The objective of the study was to determine the clinical utility of brain natriuretic peptide (NT‐proBNP) for prediction of moderate to severe bronchopulmonary dysplasia (BPD). We hypothesized that elevated NT‐proBNP levels at 4 weeks of postnatal age may predict the severity of BPD in preterm infants.Study Design: The study design was a prospective observational study. The research team enrolled and followed a cohort of 70 infants with gestational age less than or equal to 30 weeks. The plasma NT‐proBNP levels were measured at the postnatal day 28th. We further followed and categorized infants into two groups. Infants with no or mild BPD (Group 1) and infants with moderate or severe BPD (Group 2). We compared plasma NT‐proBNP levels at 28th day of postnatal life between Groups 1 and 2. The difference in NT‐proBNP levels on day 28th between groups was used to predict the severity of BPD.Results: Plasma NT‐proBNP was significantly elevated in Group 2 compared with Group 1, median (IQR) of 845 pg/mL (553, 1632) compared with 726 pg/mL (391, 923), P = 0.02. NT‐proBNP had a fair predictive accuracy (C statistics of 0.68) to determine moderate to severe BPD.Conclusion: NT‐proBNP may be a useful biomarker in conjunction with clinical factors as a predictor of severe BPD. For future directions, the trend of NT‐proBNP in infants with BPD may have clinical significance in monitoring of the disease.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR000117)
This publication has 31 references indexed in Scilit:
- Predictors of Bronchopulmonary DysplasiaClinics in Perinatology, 2012
- Bronchopulmonary DysplasiaPediatrics in Review, 2012
- Clinical features of paediatric pulmonary hypertension: a registry studyThe Lancet, 2012
- Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature InfantsAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research NetworkPediatrics, 2010
- N-terminal pro-B-type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia in Premature InfantsAmerican Journal of Perinatology, 2009
- Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight InfantsPediatrics, 2009
- Longitudinal Changes of Brain-Type Natriuretic Peptide in Preterm NeonatesPediatrics, 2006
- Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routineHeart, 2005
- Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted AgePediatrics, 1999